Wide dissemination of extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli and Klebsiella spp. in acute care and rehabilitation hospitals

Epidemiology and Infection

Volumn 140, Issue 3, 2012, Pages 528-534

  Kohlenberg, A ^a   Schwab, F ^b   Ruden H ^c  

^a UNIVERSITY OF COLOGNE   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c Helios Hospital Group   (Germany)

Author keywords

Antibiotic resistance; hospital acquired (nosocomial) infections; surveillance system

Indexed keywords

EXTENDED SPECTRUM BETA LACTAMASE;

ARTICLE; COMMUNICABLE DISEASE; CONTROLLED STUDY; DISEASE SURVEILLANCE; EMERGENCY CARE; ESCHERICHIA COLI; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ENTEROBACTERIACEAE; GERMANY; HOSPITAL INFECTION; HOSPITAL PATIENT; HUMAN; INCIDENCE; INFECTION RISK; KLEBSIELLA; NONHUMAN; PROSPECTIVE STUDY; REHABILITATION CENTER; RISK ASSESSMENT; RISK FACTOR;

BETA-LACTAMASES; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; GERMANY; HOSPITALS; HUMANS; INCIDENCE; KLEBSIELLA; KLEBSIELLA INFECTIONS; PROSPECTIVE STUDIES;

EID: 84856299242     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268811000781     Document Type: Article

References (27)

1. Schwaber MJ, Carmeli Y. Mortality and delay in effective therapy associated with extended-spectrum beta-lactamase production in Enterobacteriaceae bacteraemia : a systematic review and meta-analysis. Journal of Antimicrobial Chemotherapy 2007; 60: 913-920. (Pubitemid 47617735)
2. Laurent C, et al. Intensive care unit outbreak of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae controlled by cohorting patients and reinforcing infection control measures. Infection Control and Hospital Epidemiology 2008; 29: 517-524. (Pubitemid 351918030)
3. Quale JM, et al. Molecular epidemiology of a citywide outbreak of extended-spectrum beta-lactamaseproducing Klebsiella pneumoniae infection. Clinical Infectious Diseases 2002; 35: 834-841.
4. Rodriguez-Bano J, Navarro MD. Extended-spectrum beta-lactamases in ambulatory care : a clinical perspective. Clinical Microbiology and Infection 2008; 14 (Suppl. 1) : 104-110. (Pubitemid 350284181)
5. Pitout JD, et al. Emergence of Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs) in the community. Journal of Antimicrobial Chemotherapy 2005; 56: 52-59. (Pubitemid 41418336)
6. Mesa RJ, et al. Extended-spectrum beta-lactamaseproducing Enterobacteriaceae in different environments (humans, food, animal farms and sewage). Journal of Antimicrobial Chemotherapy 2006; 58: 211-215. (Pubitemid 44295011)
7. Valverde A, et al. High rate of intestinal colonization with extended-spectrum-beta-lactamase-producing organisms in household contacts of infected community patients. Journal of Clinical Microbiology 2008; 46: 2796-2799.
8. Rooney PJ, et al. Nursing homes as a reservoir of extended-spectrum beta-lactamase (ESBL)-producing ciprofloxacin-resistant Escherichia coli. Journal of Antimicrobial Chemotherapy 2009; 64: 635-641.
9. Tä ngdén T, et al. Foreign travel is a major risk factor for colonization with Escherichia coli producing CTX-M-type extended-spectrum beta-lactamases : a prospective study with Swedish volunteers. Antimicrobial Agents and Chemotherapy 2010; 54: 3564-3568.
10. Laupland KB, et al. Community-onset extendedspectrum beta-lactamase (ESBL) producing Escherichia coli : importance of international travel. Journal of Infection 2008; 57: 441-448.
11. Coque TM, Baquero F, Canton R. Increasing prevalence of ESBL-producing Enterobacteriaceae in Europe. Eurosurveillance 2008; 13(47) : 19044.
12. Moor CT, et al. Extended-spectrum beta-lactamase (ESBL)-producing enterobacteria : factors associated with infection in the community setting, Auckland, New Zealand. Journal of Hospital Infection 2008; 68: 355-362.
13. Bercion R, et al. Increasing prevalence of antimicrobial resistance among Enterobacteriaceae uropathogens in Bangui, Central African Republic. Journal of Infection in Developing Countries 2009; 3: 187-190.
14. Pitout JD, Laupland KB. Extended-spectrum betalactamase-producing Enterobacteriaceae : an emerging public-health concern. Lancet Infectious Diseases 2008; 8: 159-166. (Pubitemid 351249250)
15. Meyer E, Gastmeier P, Schwab F. The burden of multiresistant bacteria in German intensive care units. Journal of Antimicrobial Chemotherapy 2008; 62: 1474-1476.
16. Meyer E, et al. Dramatic increase of third-generation cephalosporin-resistant E. coli in German intensive care units : secular trends in antibiotic drug use and bacterial resistance, 2001 to 2008. Critical Care 2010; 14: R113.
17. Sax H, et al. 'My five moments for hand hygiene' : a user-centred design approach to understand, train, monitor and report hand hygiene. Journal of Hospital Infection 2007; 67: 9-21. (Pubitemid 47377724)
18. Kaier K, et al. The impact of antimicrobial drug consumption and alcohol-based hand rub use on the emergence and spread of extended-spectrum betalactamase-producing strains : a time-series analysis. Journal of Antimicrobial Chemotherapy 2009; 63: 609-614.
19. Meyer E, et al. Impact of restriction of third generation cephalosporins on the burden of third generation cephalosporin resistant K. pneumoniae and E.coli in an ICU. Intensive Care Medicine 2009; 35: 862-870.
20. Kohlenberg A, et al. Regional trends in multidrugresistant infections in German intensive care units : a real-time model for epidemiological monitoring and analysis. Journal of Hospital Infection 2009; 73: 239-245.
21. Kola A, et al. Surveillance of extended-spectrum beta-lactamase-producing bacteria and routine use of contact isolation : experience from a three-year period. Journal of Hospital Infection 2007; 66: 46-51. (Pubitemid 46657123)
22. Ben-Ami R, et al. Influx of extended-spectrum beta-lactamase-producing enterobacteriaceae into the hospital. Clinical Infectious Diseases 2006; 42: 925-934.
23. Chaberny IF, et al. Development of a surveillance system for methicillin-resistant Staphylococcus aureus in German hospitals. Infection Control and Hospital Epidemiology 2007; 28: 446-452. (Pubitemid 46658058)
24. Gastmeier P, et al. Surveillance of Clostridium difficileassociated diarrhoea with the German nosocomial infection surveillance system KISS (CDAD-KISS). International Journal of Antimicrobial Agents 2009; 33 (Suppl. 1) : S19-S23.
25. Meyer E, et al. Should we screen patients for extendedspectrum beta-lactamase-producing enterobacteriaceae in intensive care units ? Infection Control and Hospital Epidemiology 2009; 30: 103-105.
26. Reddy P, et al. Screening for extended-spectrum beta-lactamase-producing Enterobacteriaceae among high-risk patients and rates of subsequent bacteremia. Clinical Infectious Diseases 2007; 45: 846-852. (Pubitemid 47580375)
27. Harris AD, et al. How important is patient-to-patient transmission in extended-spectrum beta-lactamase Escherichia coli acquisition. American Journal of Infection Control 2007; 35: 97-101. (Pubitemid 46283603)